07-01-22 The first CRISPR gene-editing drug, designed to treat blood disorders, could be on the market by 2023. Here’s what it means for the future of drug development. [Images: Julia Zolotova/Unsplash; Rawpixel] BY SY MUKHERJEE4 MINUTE READ Until recently, CRISPR—the gene-editing technology
The first CRISPR gene-editing drug is coming—possibly as soon as next year
